ALAN LEWIS Insider Trading $BMRN BIOMARIN PHARMACEUTICAL INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ALAN LEWIS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ALAN LEWIS. ALAN LEWIS is Director in BIOMARIN PHARMACEUTICAL INC ($BMRN).
ALAN LEWIS in BIOMARIN PHARMACEUTICAL INC
Trading Symbol: BMRNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ALAN LEWIS: Director
Holdings: 21,400 shares
Current Value: $1,902,674
Latest Transaction: Dec 08 2014
$BMRN Market Capitalization: $15.63B
$BMRN Previous Close: $88.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ALAN LEWIS in BIOMARIN PHARMACEUTICAL INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 08 2014 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | M | 21.51 | 7,500 | 161,325 | 0 | |
Dec 08 2014 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 89.90 | 7,500 | 674,225 | 21,400 | 28.9 K to 21.4 K (-25.95 %) |
Dec 08 2014 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Buy | M | 21.51 | 7,500 | 161,325 | 28,900 | 21.4 K to 28.9 K (+35.05 %) |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 63.10 | 6,600 | 416,460 | 6,600 | |
Jun 06 2014 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Grant | A | 0.00 | 2,100 | 0 | 21,400 | 19.3 K to 21.4 K (+10.88 %) |
Dec 11 2013 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | M | 38.59 | 7,500 | 289,425 | 0 | |
Dec 11 2013 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | M | 26.49 | 15,000 | 397,350 | 0 | |
Dec 11 2013 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 69.91 | 22,500 | 1,572,982 | 19,300 | 41.8 K to 19.3 K (-53.83 %) |
Dec 11 2013 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Buy | M | 38.59 | 7,500 | 289,425 | 41,800 | 34.3 K to 41.8 K (+21.87 %) |
Dec 11 2013 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Buy | M | 26.49 | 15,000 | 397,350 | 34,300 | 19.3 K to 34.3 K (+77.72 %) |
May 17 2013 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 67.81 | 8,500 | 576,385 | 8,500 | |
May 17 2013 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Grant | A | 0.00 | 3,400 | 0 | 19,300 | 15.9 K to 19.3 K (+21.38 %) |
May 17 2013 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 67.81 | 8,500 | 576,385 | 8,500 | |
May 17 2013 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Grant | A | 0.00 | 3,400 | 0 | 19,300 | 15.9 K to 19.3 K (+21.38 %) |
Feb 28 2013 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | M | 21.51 | 7,500 | 161,325 | 46,000 | |
Feb 28 2013 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | M | 14.39 | 7,500 | 107,925 | 53,500 | |
Feb 28 2013 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | M | 38.59 | 7,500 | 289,425 | 61,000 | |
Feb 28 2013 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 56.57 | 22,500 | 1,272,762 | 15,900 | 38.4 K to 15.9 K (-58.59 %) |
Feb 28 2013 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Buy | M | 21.51 | 7,500 | 161,325 | 38,400 | 30.9 K to 38.4 K (+24.27 %) |
Feb 28 2013 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Buy | M | 14.39 | 7,500 | 107,925 | 30,900 | 23.4 K to 30.9 K (+32.05 %) |
Feb 28 2013 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Buy | M | 38.59 | 7,500 | 289,425 | 23,400 | 15.9 K to 23.4 K (+47.17 %) |
Nov 09 2012 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | M | 17.33 | 15,000 | 259,950 | 68,500 | |
Nov 09 2012 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 46.80 | 15,000 | 702,000 | 15,900 | 30.9 K to 15.9 K (-48.54 %) |
Nov 09 2012 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Buy | M | 17.33 | 15,000 | 259,950 | 30,900 | 15.9 K to 30.9 K (+94.34 %) |
Aug 06 2012 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | M | 14.21 | 30,000 | 426,300 | 83,500 | |
Aug 06 2012 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 37.57 | 40,000 | 1,502,756 | 15,900 | 55.9 K to 15.9 K (-71.56 %) |
Aug 06 2012 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Buy | M | 14.21 | 30,000 | 426,300 | 55,900 | 25.9 K to 55.9 K (+115.83 %) |
May 10 2012 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 37.46 | 8,500 | 318,410 | 113,500 | |
May 10 2012 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Grant | A | 0.00 | 3,400 | 0 | 25,900 | 22.5 K to 25.9 K (+15.11 %) |
May 16 2011 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 26.49 | 15,000 | 397,350 | 105,000 | |
May 16 2011 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Grant | A | 0.00 | 2,500 | 0 | 22,500 | 20 K to 22.5 K (+12.50 %) |
May 14 2010 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 21.51 | 15,000 | 322,650 | 90,000 | |
May 14 2010 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Grant | A | 0.00 | 2,500 | 0 | 20,000 | 17.5 K to 20 K (+14.29 %) |
May 27 2009 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 0 | |
May 27 2009 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Grant | A | 0.00 | 2,500 | 0 | 17,500 | 15 K to 17.5 K (+16.67 %) |
May 14 2009 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 14.39 | 15,000 | 215,850 | 75,000 | |
May 14 2009 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Grant | A | 0.00 | 2,500 | 0 | 15,000 | 12.5 K to 15 K (+20.00 %) |
Jul 08 2008 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
Jul 08 2008 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Grant | A | 0.00 | 2,500 | 0 | 12,500 | 10 K to 12.5 K (+25.00 %) |
May 27 2008 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 5,000 | |
May 27 2008 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 38.59 | 15,000 | 578,850 | 60,000 | |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | M | 7.72 | 30,000 | 231,600 | 45,000 | |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.25 | 400 | 8,100 | 10,000 | 10.4 K to 10 K (-3.85 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.00 | 8,300 | 166,000 | 10,400 | 18.7 K to 10.4 K (-44.39 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.01 | 200 | 4,002 | 18,700 | 18.9 K to 18.7 K (-1.06 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.03 | 200 | 4,006 | 18,900 | 19.1 K to 18.9 K (-1.05 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.07 | 1,600 | 32,112 | 19,100 | 20.7 K to 19.1 K (-7.73 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.08 | 200 | 4,016 | 20,700 | 20.9 K to 20.7 K (-0.96 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.09 | 1,000 | 20,090 | 20,900 | 21.9 K to 20.9 K (-4.57 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.11 | 200 | 4,022 | 21,900 | 22.1 K to 21.9 K (-0.90 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.12 | 200 | 4,024 | 22,100 | 22.3 K to 22.1 K (-0.90 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.13 | 1,600 | 32,208 | 22,300 | 23.9 K to 22.3 K (-6.69 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.14 | 800 | 16,112 | 23,900 | 24.7 K to 23.9 K (-3.24 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.15 | 600 | 12,090 | 24,700 | 25.3 K to 24.7 K (-2.37 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.16 | 1,000 | 20,160 | 25,300 | 26.3 K to 25.3 K (-3.80 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.17 | 600 | 12,102 | 26,300 | 26.9 K to 26.3 K (-2.23 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.18 | 1,500 | 30,270 | 26,900 | 28.4 K to 26.9 K (-5.28 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.19 | 1,100 | 22,209 | 28,400 | 29.5 K to 28.4 K (-3.73 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.21 | 300 | 6,063 | 29,500 | 29.8 K to 29.5 K (-1.01 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.23 | 100 | 2,023 | 29,800 | 29.9 K to 29.8 K (-0.33 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.24 | 100 | 2,024 | 29,900 | 30 K to 29.9 K (-0.33 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Buy | M | 7.72 | 30,000 | 231,600 | 30,000 | 0 to 30 K |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 17.33 | 15,000 | 259,950 | 75,000 | |
Aug 17 2006 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 14.21 | 30,000 | 426,300 | 60,000 | |
Jul 06 2005 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 7.72 | 30,000 | 231,600 | 30,000 |
Page: 1